| Literature DB >> 28461965 |
Nicola Ratto1, Chiara Arrigoni1, Federica Rosso2, Matteo Bruzzone2, Federico Dettoni2, Davide Edoardo Bonasia2, Roberto Rossi2.
Abstract
Total joint arthroplasty (TJA) is one of the most common orthopaedic procedures. Nevertheless, several complications can lead to implant failure.Peri-prosthetic joint infections (PJI) certainly represent a significant challenge in TJA, constituting a major cause of prosthetic revision. The surgeon may have an important role in reducing the PJI rate by limiting the impact of significant risk factors associated to either the patient, the operative environment or the post-operative care.In the pre-operative period, several preventive measures may be adopted to manage reversible medical comorbidities. Other recognised pre-operative risk factors are urinary tract infections, intra-articular corticosteroid injections and nasal colonisation with Staphylococcus (S.) aureus, particularly the methicillin-resistant strain (MRSA).In the intra-operative setting, protective measures for PJI include antibiotic prophylaxis, surgical-site antisepsis and use of pre-admission chlorhexidine washing and pulsed lavage during surgery. In this setting, the use of plastic adhesive drapes and sterile stockinette, as well as using personal protection systems, do not clearly reduce the risk of infection. On the contrary, using sterile theatre light handles and splash basins as well as an increased traffic in the operating room are all associated with an increased risk for PJI.In the post-operative period, other infections causing transient bacteraemia, blood transfusion and poor wound care are considered as risk factors for PJI. Cite this article: Ratto N, Arrigoni C, Rosso F, Bruzzone M, Dettoni F, Bonasia DE, Rossi R. Total knee arthroplasty and infection: how surgeons can reduce the risks. EFORT Open Rev 2016;1: 339-344 DOI: 10.1302/2058-5241.1.000032.Entities:
Keywords: infection; risk factors; surgeons; total knee arthroplasty
Year: 2017 PMID: 28461965 PMCID: PMC5367521 DOI: 10.1302/2058-5241.1.000032
Source DB: PubMed Journal: EFORT Open Rev ISSN: 2058-5241
Potential risk factors for development of surgical site infection or peri-prosthetic joint infection after elective total joint arthroplasty, according to The International Consensus on Periprosthetic Joint Infection[7]
| Comorbidities |
| Poorly controlled diabetes mellitus (glucose > 200 mg/L or HbA1C >7%) |
| Poor nutritional state |
| Morbid obesity (BMI >40 Kg/m2) |
| Prolonged hospital admission |
| Severe immunodeficiency |
| Inflammatory arthropathy (rheumatoid arthritis) |
| Anaemia |
| Male sex |
| Excessive smoking (> one pack per day) |
| Excessive alcohol consumption (> 40 units per week) |
| Intravenous drug abuse |
| Active liver disease |
| Chronic renal disease |
| Diagnosis of post-traumatic arthritis |
| Prior surgical procedure in the affected joint |
BMI, body mass index; HbA1c, glycated haemoglobin.
Pre-operative modifiable and non-modifiable risk factors; measures the surgeon can adopt to reduce impact of risk factors on development of PJI
| Non-modifiable risk factor | Conditions favouring PJI | Role of the surgeon |
|---|---|---|
| Obesity[ | BMI > 40 Kg/m2 | Weight loss |
| Anemia[ | Blood transfusion | Iron supplementation; erythropoietin therapy |
| Nutritional status[ | Serum albumin level < 34g/l | Correction of abnormal laboratory parameters |
| Diabetes[ | HbA1c level > 8 | Accurate peri-operative monitoring of blood glucose |
| Smoking[ | >1 pack/day or 25 cigarettes | Cessation between four and six weeks before surgery |
| Oral corticosteroid therapy[ | Steroid doses over 15 mg/day | Reduction or suspension |
| Rheumatoid arthritis[ | Steroid doses over 15 mg/day | Reduction or suspension of immunosoppressive therapy with reumatologist collaboration |
| Modifiable risk factor | Correlation with PJI incidence | Role of the surgeon |
| Urinary tract infection[ | Unclear | Delay surgery when urine leukocytes count > 1 × 10(4)/mL and bacterial count > 1 × 10(3)/mL |
| Intra-articular corticosteroid injections[ | Unclear | Surgical delay of between six and 12 months |
| Nasal colonisation with | Influencing, predisposing | Nasal MRSA bonification with mupirocin application (debated efficacy) |
PJI, peri-prosthetic joint infections; BMI, body mass index; HbA1c, glycated haemoglobin; MRSA, methicillin-resistant staphylococcus aureus; S. aureus, staphylococcus aureus
Intra-operative factors potentially associated with PJIs
| Correlated to reduced PJI risk | Correlated to increased PJI risk | Unclear factors | Potential sources of infection | |
|---|---|---|---|---|
| Intra-operative factors (surgeon’s role) | Antibiotic prophylaxis | Portable devices | Surgical gloves | Sterile stockinette (no foot preparation) |
| Pre-admission chlorhexidine cloths | Splash basins | Laminar flow | Personal protection system | |
| Surgical site antisepsis | Traffic in operating room | Antibiotic-loaded bone cement | Light handle | |
| Ultraviolet light | Use of plastic adhesive drapes | |||
| Pulsed lavage | ||||
| Reduced operative time (< 2.5 hours) |
PJI, peri-prosthetic joint infections